|
|
||||||||
The Journal of Immunology, Vol 144, Issue 4 1288-1294, Copyright © 1990 by American Association of Immunologists
ARTICLES |
BA Vandekerckhove, G Datema, F Koning, E Goulmy, GG Persijn, JJ Van Rood, FH Claas and JE De Vries
Department of Immunohaematology, University Hospital of Leiden, The Netherlands.
In the present study the transplant specific CTL repertoire of a patient (HLA:A1,3, B8,18, Cw5,7 DR3, DQw2, DPw3) with a long term surviving HLA mismatched kidney graft (HLA: A1,24 B8,27 Cw2,7, DR3, w13 DQw2,6 DPw1,3) has been investigated. This patient was unable to generate specific cytolytic activity against donor-derived PHA-blasts in the MLC in which donor spleen cells or B lymphoblastoid cell line were used as stimulator cells. In addition, the CTL precursor frequencies against donor alloantigens were very low (1/67,000). The patient had otherwise normal immune responses in vivo and in vitro and no signs of transplant rejection. Transplant specific CTL clones were generated in high frequencies (1/195) from T cell bulk cultures activated by PHA in the absence of any sensitization by donor Ag in vitro. The repertoire of 14 donor-reactive CTL clones (12 TCR-alpha beta+ and 2 TCR-gamma delta+) was analyzed. Two TCR-alpha beta+ CD8+ clones were specific for B27. Ten TCR-alpha beta+ CTL clones directed against class II HLA Ag were isolated. Seven of these were CD4+ and recognized DRw13 (3), DQw6 (3), and DPw1 (1), whereas three of these clones were CD4-CD8+ recognizing DRw13 (1) and DQw6 (2). In addition, two donor-specific TCR-gamma delta+ CTL clones were obtained recognizing HLA-A9(23,24) and DQw6. Our data indicate that the precursors of CTL clones specifically directed against donor class I or II HLA Ag are not deleted from the repertoire and that part of this reactivity resides in the TCR-gamma delta+ fraction.
This article has been cited by other articles:
![]() |
T. M. Holling, M. W. T. Bergevoet, L. Wilson, M. C. J. A. Van Eggermond, E. Schooten, R. D. M. Steenbergen, P. J. F. Snijders, M. J. Jager, and P. J. Van den Elsen A Role for EZH2 in Silencing of IFN-{gamma} Inducible MHC2TA Transcription in Uveal Melanoma J. Immunol., October 15, 2007; 179(8): 5317 - 5325. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Holling, E. Schooten, A. W. Langerak, and P. J. van den Elsen Regulation of MHC class II expression in human T-cell malignancies Blood, February 15, 2004; 103(4): 1438 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. M. Nagarajan, A. Peijnenburg, S. J. P. Gobin, J. M. Boss, and P. J. van den Elsen Novel Mutations Within the RFX-B Gene and Partial Rescue of MHC and Related Genes Through Exogenous Class II Transactivator in RFX-B-Deficient Cells J. Immunol., April 1, 2000; 164(7): 3666 - 3674. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Peijnenburg, M. J. C. A. Van Eggermond, S. J. P. Gobin, R. Van den Berg, B. C. Godthelp, J. M. J. J. Vossen, and P. J. Van den Elsen Discoordinate Expression of Invariant Chain and MHC Class II Genes in Class II Transactivator-Transfected Fibroblasts Defective for RFX5 J. Immunol., July 15, 1999; 163(2): 794 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nishimura, J. Washizu, Y. Naiki, T. Hara, Y. Fukui, T. Sasazuki, and Y. Yoshikai MHC Class II-Dependent NK1.1+ {gamma}{delta} T Cells Are Induced in Mice by Salmonella Infection J. Immunol., February 1, 1999; 162(3): 1573 - 1581. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van Rood and F. Claas The influence of allogeneic cells on the human T and B cell repertoire Science, June 15, 1990; 248(4961): 1388 - 1393. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |